Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in CRDF — Cardiff Oncology, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$150,979
+$1,358 QoQ
Shares Held
116,138
+25.7% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 104 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Derivatives in CRDF

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$14,690
PutShares
11,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. CRDF ranks #254 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in CRDF

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $150,979 116,138
2026-06-30 $14,690 11,300
2026-03-31 $438,858 270,900
2026-03-31 $149,621 92,359
2026-03-31 $99,306 61,300
2025-12-31 $61,370 21,840
2025-12-31 $158,484 56,400
2025-12-31 $550,198 195,800
2025-09-30 $132,058 64,106
2025-09-30 $379,246 184,100
2025-09-30 $196,318 95,300
2025-06-30 $104,580 33,200
2025-06-30 $1,666,529 529,057
2025-06-30 $131,355 41,700
2025-03-31 $98,282 31,300
2025-03-31 $1,188,317 378,445
2024-12-31 $1,122,506 258,642
2024-12-31 $177,940 41,000
2024-12-31 $195,300 45,000
2024-09-30 $423,996 158,800
2024-09-30 $97,455 36,500
2024-06-30 $59,496 26,800
2024-06-30 $79,853 35,970
2024-06-30 $289,932 130,600
2024-03-31 $531,864 99,600
2024-03-31 $444,571 83,253
2024-03-31 $104,130 19,500
2023-12-31 $33,715 22,781
2023-12-31 $16,132 10,900
2023-12-31 $41,440 28,000
2023-09-30 $66,025 47,500
2023-09-30 $111,439 80,172
2023-09-30 $225,458 162,200
2023-06-30 $138,920 94,504
2023-03-31 $317,629 192,503
2023-03-31 $94,545 57,300
2022-12-31 $255,333 182,381
2022-12-31 $21,280 15,200
2022-09-30 $68,838 44,700
2022-09-30 $316,882 205,768
2022-06-30 $83,820 38,100
2022-06-30 $701,793 318,997
2022-03-31 $250,866 101,156
2022-03-31 $167,400 67,500
2021-12-31 $1,539,533 256,162
2021-12-31 $649,681 108,100
2021-09-30 $1,306,692 196,200
2021-09-30 $249,750 37,500
2021-09-30 $1,329,575 199,636
2021-06-30 $908,795 136,661